B7-1 (CD80), B7-2 (CD86), interleukin-12 and transforming growth factor- β mRNA expression in CSF and peripheral blood mononuclear cells from multiple sclerosis patients

Journal of Neuroimmunology

Volumn 91, Issue 1-2, 1998, Pages 198-203

  Monteyne, Philippe ^a   Guillaume, Benoit ^a   Sindic, Christian J m ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

B7 1; B7 2; CSF cells; Multiple sclerosis; Peripheral blood mononuclear cells

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 12; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL SPREADING; CEREBROSPINAL FLUID; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATORY CELL; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ACTINS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CEREBROSPINAL FLUID; GENE EXPRESSION; HUMANS; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MULTIPLE SCLEROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032476639     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00180-5     Document Type: Article

References (21)

1. + T cells via CD40 ligand. Proc. Natl. Acad. Sci. USA. 94:1997;599-603.
2. Beck J., Rondot P., Catinot L., Falcoff E., Kirchner H., Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokine trigger off exacerbations? Acta Neurol. Scand. 78:1988;318-323.
3. Chofflon M., Juillard C., Juillard P., Gauthier G., Grau G.E. Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. Eur. Cytokine Netw. 3:1992;523-531.
4. Correale J., McMillan M., Li S., McCarthy K., Le T., Weiner L.P. Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12. J. Neuroimmunol. 72:1997;27-43.
5. De Simone R., Giampaolo A., Giometto B., Gallo P., Levi G., Peschle C., Aloisi F. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol. 54:1994;175-187.
6. Drulovic J., Mostarica-Stojkovic M., Levic Z., Stojsavljevic N., Pravica V., Mesaros S. Interleukin-12 and tumor necrosis factor-α levels in cerebrospinal fluid of multiple sclerosis patients. J. Neurol. Sci. 147:1997;145-150.
7. Freeman G.J., Boussiotis V.A., Anumanthan A., Bernstein G.M., Ke X.-Y., Rennert P.D., Gray G.S., Gribben J.G., Nadler L.M. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:1995;523-532.
8. + B cells in active multiple sclerosis and reversal by interferon β-1b therapy. J. Clin. Invest. 99:1997;2664-2671.
9. Kuchroo V.K., Prabhu Das M., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:1995;707-718.
10. Leonard J.P., Waldburger K.E., Goldman S.J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:1995;381-386.
11. Link J., Söderström M., Olsson T., Höjeberg B., Ljungdahl A., Link H. Increased transforming growth factor-β, interleukin-4, and interferon-γ in multiple sclerosis. Ann. Neurol. 36:1994;379-386.
12. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Dal Canto M.C., Bluestone J.A. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:1995;739-745.
13. Monteyne Ph., Van Laere V., Marichal R., Sindic C.J.M. Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis. Detection by RT-PCR without in vitro stimulation. J. Neuroimmunol. 80:1997;137-142.
14. Monteyne Ph., Renauld J.-C., Van Broeck J., Dunne D., Brombacher F., Coutelier J.-P. IL-4-independent regulation of in vivo IL-9 expression. J. Immunol. 159:1997;2616-2623.
15. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtelotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
16. Rieckmann P., Albrecht M., Kitze B., Weber T., Tumani H., Broocks A., Luër W., Helwig A., Poser S. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37:1995;82-88.
17. Sharief M.K., Hentges R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. New Engl. J. Med. 325:1991;467-472.
18. Svenningsson A., Dotevall L., Stemme S., Andersen O. Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease. J. Neuroimmunol. 75:1997;59-68.
19. Thompson C.B. Distinct roles for costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell. 81:1995;979-982.
20. Williams K., Ulvestad E., Antel J.P. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24:1994;3031-3037.
21. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe N., Cuzner L., Hafler D.A. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1995;1985-1996.